Answers are grounded in this paper and cite their sources.
1.1. Background: Renal Cell Carcinoma (RCC) accounts for approximately 3% of all malignant diseases. As the population in the Western world grows older more patients are treated with Dual Antiplatelet Therapy (DAPT) for cardio-vascular diseases. We sought to understand the morbidity associated with open surgical for presumably malignant renal masses in patients undergoing open renal surgery.
No takes yet. Share an insight, caveat, or question.
Staehler et al. (2023) studied this question.
Synapse has enriched 7 related papers. Consider them for comparative context: